Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Scientific Reports|November 29, 2025
Simplified monitoring of sofosbuvir/velpatasvir in Japanese patients with chronic hepatitis C based on a retrospective analysis of a prospective multicenter cohortGoki Suda, Masaru Baba, Yoshiya Yamamoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 10, 2021
Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteriaTakuya Sho, Goki Suda, Koji Ogawa, et al.
Cancers|August 26, 2022
Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150Takuya Sho, Goki Suda, Yoshiya Yamamoto, et al.
Journal of Gastroenterology|February 20, 2019
Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infectionGoki Suda, Chitomi Hasebe, Masami Abe, et al.
The Journal of Infection|February 28, 2026
Tenofovir alafenamide prevents HBV reactivation in anticancer/immunosuppression: 24-month multicentre prospective studyGoki Suda, Masatsugu Ohara, Masaru Baba, et al.
Liver Cancer|June 16, 2023
Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab TreatmentShunichi Hosoda, Goki Suda, Takuya Sho, et al.
Journal of Medical Virology|January 4, 2023
Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation-related hepatitisGoki Suda, Masaru Baba, Yoshiya Yamamoto, et al.
Journal of Gastroenterology|July 19, 2018
Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infectionGoki Suda, Masayuki Kurosaki, Jun Itakura, et al.
Biomarker Research|September 24, 2025
Long non-coding RNA PWRN4 associated with post-SVR hepatocellular carcinoma: a genome-wide association studyGoki Suda, Masaya Sugiyama, Hayato Hikita, et al.
Journal of Gastroenterology|June 1, 2017
Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in JapanGoki Suda, Norihiro Furusyo, Hidenori Toyoda, et al.
Pageof 10